{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:39:07Z","timestamp":1791895147159,"version":"4.3.4"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.mib.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T18:12:42Z","timestamp":1510855962000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Modulating host immune responses to fight invasive fungal infections"],"prefix":"10.1016","volume":"40","author":[{"given":"James E","family":"Scriven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Tenforde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M","family":"Levitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2017.10.018_bib0495","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the transplant-associated infection surveillance network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0500","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0505","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0510","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0515","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0520","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0525","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","article-title":"Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions","volume":"10","author":"Haddow","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0530","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/655785","article-title":"Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome","volume":"202","author":"Boulware","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0535","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1097\/QAD.0b013e3283614a8d","article-title":"Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome","volume":"27","author":"Chang","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.mib.2017.10.018_sbref0540","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/infdis\/jiv067","article-title":"Early ART after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial","volume":"212","author":"Scriven","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0545","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical features and serum biomarkers in HIv immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study","volume":"7","author":"Boulware","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0550","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in Sub-Saharan Africa","volume":"50","author":"Makadzange","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0555","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0560","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4102\/sajhivmed.v14i2.82","article-title":"Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update","volume":"14","author":"Govender","year":"2013","journal-title":"S Afr J HIV Med"},{"key":"10.1016\/j.mib.2017.10.018_sbref0565","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40588-016-0033-7","article-title":"Immune reconstitution inflammatory syndrome in invasive fungal infections: what we know and what we need to know?","volume":"3","author":"Chang","year":"2016","journal-title":"Curr Clin Micro Rep"},{"key":"10.1016\/j.mib.2017.10.018_bib0570","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/430606","article-title":"An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0575","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/527390","article-title":"Adjuvant corticosteroid therapy for chronic disseminated candidiasis","volume":"46","author":"Legrand","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0580","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.3584","article-title":"Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin","volume":"34","author":"Palchaudhuri","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2017.10.018_bib0585","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198806023182202","article-title":"Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium","volume":"318","author":"Gabrilove","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0590","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: from granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.mib.2017.10.018_bib0595","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1439-0507.1991.tb00630.x","article-title":"Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Candida infections in normal and immunosuppressed mice","volume":"34","author":"Polak-Wyss","year":"1991","journal-title":"Mycoses"},{"key":"10.1016\/j.mib.2017.10.018_bib0600","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/AAC.48.8.3154-3158.2004","article-title":"Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis","volume":"48","author":"Patera","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2017.10.018_bib0605","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mib.2017.10.018_bib0610","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/0003-4819-147-6-200709180-00010","article-title":"Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection","volume":"147","author":"Sung","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0615","series-title":"Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego)","first-page":"479","article-title":"A double-blind, randomized, placebo-controlled phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and candidemia in nonneutropenic patients","author":"Kullberg","year":"1998"},{"key":"10.1016\/j.mib.2017.10.018_bib0620","author":"Hazel","year":"1999","journal-title":"Hematology"},{"key":"10.1016\/j.mib.2017.10.018_bib0625","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.mib.2017.10.018_bib0630","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1189\/jlb.70.6.868","article-title":"In vivo GM-CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages","volume":"70","author":"Brummer","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mib.2017.10.018_bib0635","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.00760-07","article-title":"Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis","volume":"52","author":"Quezada","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2017.10.018_bib0640","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00002030-199901140-00007","article-title":"Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients","volume":"13","author":"Tascini","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.mib.2017.10.018_bib0645","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.mib.2017.10.018_bib0650","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood.V86.2.457.bloodjournal862457","article-title":"A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55\u201370 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)","volume":"86","author":"Rowe","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.mib.2017.10.018_bib0655","first-page":"2722","volume":"91","author":"Witz","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.mib.2017.10.018_sbref0660","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial","volume":"33","author":"Wan","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mib.2017.10.018_bib0665","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1310\/LF5T-WYY7-0U3E-G8BQ","article-title":"Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study","volume":"1","author":"Vazquez","year":"2000","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.mib.2017.10.018_bib0670","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/clinids\/17.4.705","article-title":"Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer","volume":"17","author":"Bodey","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0675","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1086\/320767","article-title":"Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor","volume":"32","author":"Garcia-Diaz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0680","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature12026","article-title":"M-CSF instructs myeloid lineage fate in single haematopoietic stem cells","volume":"497","author":"Mossadegh-Keller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mib.2017.10.018_sbref0685","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1084\/jem.20151975","article-title":"M-CSF improves protection against bacterial and fungal infections after hematopoietic stem\/progenitor cell transplantation","volume":"213","author":"Kandalla","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0690","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.mib.2017.10.018_bib0695","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/515645","article-title":"Candidiasis in interferon-gamma knockout (IFN-gamma\u2212\/\u2212) mice","volume":"178","author":"Balish","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0700","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/IAI.73.3.1788-1796.2005","article-title":"The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans","volume":"73","author":"Chen","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2017.10.018_bib0705","first-page":"997","article-title":"Experimental histoplasmosis in mice treated with anti-murine interferon-gamma antibody and in interferon-gamma gene knockout mice","volume":"2","author":"Clemons","year":"2000","journal-title":"Microbe"},{"key":"10.1016\/j.mib.2017.10.018_bib0710","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/432120","article-title":"Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency","volume":"41","author":"Zerbe","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0715","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1086\/605532","article-title":"Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-\u03b3 receptor 1 deficiency","volume":"49","author":"Vinh","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0720","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0725","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/IAI.61.4.1185-1193.1993","article-title":"Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon","volume":"61","author":"Roilides","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2017.10.018_bib0730","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.imlet.2011.07.008","article-title":"Study of immunological aspects of aspergillosis in mice and effect of polyene macrolide antibiotic (SJA-95) and IFN-\u03b3: a possible role of IFN-\u03b3 as an adjunct in antifungal therapy","volume":"141","author":"Naik","year":"2011","journal-title":"Immunol Lett"},{"key":"10.1016\/j.mib.2017.10.018_bib0735","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","author":"The International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0740","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0745","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jac\/46.3.437","article-title":"Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis","volume":"46","author":"Lutz","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mib.2017.10.018_bib0750","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0755","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.mib.2017.10.018_bib0760","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/425121","article-title":"Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy","volume":"39","author":"Netea","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0765","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0770","first-page":"3","article-title":"Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis","volume":"3","author":"Clemons","year":"2001","journal-title":"Microbe"},{"key":"10.1016\/j.mib.2017.10.018_bib0775","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00520-006-0041-x","article-title":"G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.mib.2017.10.018_bib0780","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.mib.2017.10.018_bib0785","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.mib.2017.10.018_bib0790","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.mib.2017.10.018_sbref0795","first-page":"1734","article-title":"Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis","volume":"215","author":"Baistrocchi","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0800","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0805","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3324\/haematol.2013.098830","article-title":"Induction of A. fumigatus specific CD4-positive T cells in patients recovering from invasive aspergillosis","volume":"99","author":"Jolink","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.mib.2017.10.018_sbref0810","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/ejh.12531","article-title":"Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants","volume":"95","author":"Perruccio","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.mib.2017.10.018_bib0815","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.165.1.381","article-title":"T cell vaccination in mice with invasive pulmonary aspergillosis","volume":"165","author":"Cenci","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0820","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.mib.2017.10.018_sbref0825","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/infdis\/jiu607","article-title":"Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections","volume":"211","author":"Stuehler","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0830","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.mib.2017.10.018_bib0835","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2017.10.018_bib0840","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0845","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.mib.2017.10.018_bib0850","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0855","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/infdis\/163.5.1114","article-title":"Improved amphotericin B activity by a monoclonal anti-Cryptococcus neoformans antibody: study during murine cryptococcosis and mechanisms of action","volume":"163","author":"Dromer","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0860","first-page":"20","article-title":"Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis","volume":"74","author":"Matthews","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.mib.2017.10.018_bib0865","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/CDLI.12.9.1063-1068.2005","article-title":"Monoclonal immunoglobulin G1 directed against Aspergillus fumigatus cell wall glycoprotein protects against experimental murine aspergillosis","volume":"12","author":"Chaturvedi","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0870","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1128\/IAI.01443-08","article-title":"Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum","volume":"77","author":"Guimaraes","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2017.10.018_bib0875","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_bib0880","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","article-title":"Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2017.10.018_bib0885","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/IAI.00278-07","article-title":"An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo","volume":"75","author":"Rachini","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.mib.2017.10.018_bib0890","doi-asserted-by":"crossref","first-page":"E2209","DOI":"10.1073\/pnas.1303573110","article-title":"Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens","volume":"110","author":"Cywes-Bentley","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2017.10.018_bib0895","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20030109","article-title":"Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts","volume":"197","author":"Wuthrich","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0900","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1164\/ajrccm\/148.3.656","article-title":"Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group","volume":"148","author":"Pappagianis","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0905","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00281-014-0460-6","article-title":"Exploiting fungal cell wall components in vaccines","volume":"37","author":"Levitz","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.mib.2017.10.018_bib0910","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0915","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","article-title":"A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection","volume":"166","author":"Fleuridor","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0920","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1128\/CVI.00463-13","article-title":"Characterization and optimization of the glucan particle-based vaccine platform","volume":"20","author":"Huang","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.mib.2017.10.018_sbref0925","doi-asserted-by":"crossref","first-page":"e01905","DOI":"10.1128\/mBio.01905-15","article-title":"Protection against experimental Cryptococcosis following vaccination with glucan particles containing Cryptococcus alkaline extracts","volume":"6","author":"Specht","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.mib.2017.10.018_bib0930","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mib.2017.10.018_bib0935","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.mib.2017.10.018_bib0940","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2017.10.018_bib0945","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.mib.2017.10.018_bib0950","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fimmu.2014.00463","article-title":"Applying convergent immunity to innovative vaccines targeting Staphylococcus aureus","volume":"5","author":"Yeaman","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.mib.2017.10.018_bib0955","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_bib0960","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00365549709011832","article-title":"Neutrophil chemotactic activity in bronchoalveolar lavage fluid of patients with AIDS-associated Pneumocystis carinii Pneumonia","volume":"29","author":"Benfield","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0965","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix318","article-title":"Adjunctive corticosteroid therapy in the treatment of coccidioidal meningitis","author":"Thompson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2017.10.018_sbref0970","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2017.10.018_sbref0975","doi-asserted-by":"crossref","first-page":"e1004754","DOI":"10.1371\/journal.ppat.1004754","article-title":"Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis","volume":"11","author":"Jarvis","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2017.10.018_sbref0980","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/infdis\/jiw007","article-title":"A glucuronoxylomannan-associated immune signature, characterized by monocyte deactivation and an increased interleukin 10 level. Is a predictor of death in cryptococcal meningitis","volume":"213","author":"Scriven","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527417301303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527417301303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:46:22Z","timestamp":1693241182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527417301303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":98,"alternative-id":["S1369527417301303"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2017.10.018","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating host immune responses to fight invasive fungal infections","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}